Jun Qi

Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States 
"Jun Qi"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Feng Y, Cai L, Pook M, et al. (2023) BRD9-SMAD2/3 orchestrates stemness and tumorigenesis in pancreatic ductal adenocarcinoma. Biorxiv : the Preprint Server For Biology
Sevinç K, Sevinç GG, Cavga AD, et al. (2022) BRD9-containing non-canonical BAF complex maintains somatic cell transcriptome and acts as a barrier to human reprogramming. Stem Cell Reports
Guan X, Cheryala N, Karim RM, et al. (2022) Bivalent BET Bromodomain Inhibitors Confer Increased Potency and Selectivity for BRDT via Protein Conformational Plasticity. Journal of Medicinal Chemistry
Ding J, Cui XG, Chen HJ, et al. (2022) Targeting circDGKD Intercepts TKI's Effects on Up-Regulation of Estrogen Receptor β and Vasculogenic Mimicry in Renal Cell Carcinoma. Cancers. 14
Zullow HJ, Sankar A, Ingram DR, et al. (2022) The FUS::DDIT3 fusion oncoprotein inhibits BAF complex targeting and activity in myxoid liposarcoma. Molecular Cell
Wang MY, Liow P, Guzman MIT, et al. (2022) Exploring Methods of Targeting Histone Methyltransferases and Their Applications in Cancer Therapeutics. Acs Chemical Biology. 17: 744-755
Zaiken MC, Flynn R, Paz KG, et al. (2022) BET-bromodomain and EZH2 inhibitor treated chronic GVHD mice have blunted germinal centers with distinct transcriptomes. Blood
Yang Y, Li L, He H, et al. (2022) Numb inhibits migration and promotes proliferation of colon cancer cells via RhoA/ROCK signaling pathway repression. Experimental Cell Research. 411: 113004
Durbin AD, Wang T, Wimalasena VK, et al. (2021) EP300 selectively controls the enhancer landscape of MYCN-amplified neuroblastoma. Cancer Discovery
Hideshima T, Mazitschek R, Qi J, et al. (2021) Correction: HDAC6 inhibitor WT161 downregulates growth factor receptors in breast cancer. Oncotarget. 12: 1736
See more...